✦ LIBER ✦

Cetuximab for the Treatment of Colorectal Cancer

✍ Scribed by Jonker, Derek J.; O'Callaghan, Chris J.; Karapetis, Christos S.; Zalcberg, John R.; Tu, Dongsheng; Au, Heather-Jane; Berry, Scott R.; Krahn, Marianne; Price, Timothy; Simes, R. John

Book ID: 111686926
Publisher: Massachusetts Medical Society
Year: 2007
Tongue: English
Weight: 301 KB
Volume: 357
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa071834

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN3 Cetuximab for the First-Line Treatm

PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Rodriguez, R.; Beltran, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Efficacy and immune mechanisms of cetuxi

Efficacy and immune mechanisms of cetuximab for the treatment of metastatic colorectal cancer

✍ Hao Zhuang; Zhen-yi Xue; Lu Wang; Xiao-yan Li; Ning Zhang; Rong-xin Zhang 📂 Article 📅 2011 🏛 Springer-Verlag ⚖ 182 KB

Appraisal of bevacizumab and cetuximab f

Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK

✍ David Barnett; Andrew Stevens; Carole Longson 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 89 KB

Cetuximab: An epidermal growth factor re

Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer

✍ Siu-Fun Wong 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 896 KB

299 Development of Novel Combination The

299 Development of Novel Combination Therapy with Dalotuzumab and GSI for the Treatment of Cetuximab Refractory Colorectal Cancer

✍ Naumov, G.; Howard, S.; Seeley, A.; Ware, C.; Reilly, J.; Cheng, J.; Sathyanaray 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

NICE guidance on cetuximab, bevacizumab,

NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy

✍ Fiona Rinaldi; Elisabeth George; Amanda I Adler 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 43 KB